IngentaConnect Search Results

Authors: Dupuy, Lesley C; Schmaljohn, Connie S

Source: Expert Review of Vaccines, Volume 8, Number 12, December 2009 , pp. 1739-1754(16)

Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles

Authors: Sharma, Deepika; Narasimhan, Balasubramanian; Kumar, Pradeep; Judge, Vikramjeet; Narang, Rakesh; De Clercq, Erik; Balzarini, Jan

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 24, Number 5, October 2009 , pp. 1161-1168(8)

Publisher: Informa Healthcare

Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II

Authors: Rehm, Kristina E.; Connor, Ramsey F.; Jones, Gwendolyn J. B.; Yimbu, Kenneth; Mannie, Mark D.; Roper, Rachel L.

Source: Immunology, Volume 128, Number 3, November 2009 , pp. 381-392(12)

Publisher: Blackwell Publishing

The proteoglycan bamacan is a host cellular ligand of vaccinia virus neurovirulence factor N1L

Authors: Mohan, Ketha VK; Zhang, Cheryl; Atreya, Chintamani

Source: Journal of NeuroVirology, Volume 15, Number 3, June 2009 , pp. 229-237(9)

Publisher: Informa Healthcare

Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection

Authors: Postigo, Antonio; Martin, Morag C.; Dodding, Mark P.; Way, Michael

Source: Cellular Microbiology, Volume 11, Number 8, August 2009 , pp. 1208-1218(11)

Publisher: Blackwell Publishing

Transgenic chloroplasts are efficient sites for high-yield production of the vaccinia virus envelope protein A27L in plant cells

Authors: Rigano, M. Manuela; Manna, Carmela; Giulini, Anna; Pedrazzini, Emanuela; Capobianchi, Maria; Castilletti, Concetta; Di Caro, Antonino; Ippolito, Giuseppe; Beggio, Paola; De Giuli Morghen, Carlo; Monti, Luigi; Vitale, Alessandro; Cardi, Teodoro

Source: Plant Biotechnology Journal, Volume 7, Number 6, August 2009 , pp. 577-591(15)

Publisher: Blackwell Publishing

Flebogamma^® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy

Author: Jorquera, J. I.

Source: Clinical & Experimental Immunology, Volume 157, Supplement 1, September 2009 , pp. 17-21(5)

Publisher: Blackwell Publishing

Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli

Authors: Bae, M.-Y.; Cho, N.-H.; Seong, S.-Y.

Source: Clinical & Experimental Immunology, Volume 157, Number 1, July 2009 , pp. 128-138(11)

Publisher: Blackwell Publishing

The new ACAM2000™ vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks

Authors: Handley, Lauren; Buller, Robert Mark; Frey, Sharon E; Bellone, Clifford; Parker, Scott

Source: Expert Review of Vaccines, Volume 8, Number 7, July 2009 , pp. 841-850(10)

Publisher: Expert Reviews

Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer

Authors: Madan, Ravi A; Arlen, Philip M; Mohebtash, Mahsa; Hodge, James W; Gulley, James L

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 7, July 2009 , pp. 1001-1011(11)

Publisher: Informa Healthcare

An E2-F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection

Authors: Dodding, Mark P.; Newsome, Timothy P.; Collinson, Lucy M.; Edwards, Ceri; Way, Michael

Source: Cellular Microbiology, Volume 11, Number 5, May 2009 , pp. 808-824(17)

Publisher: Blackwell Publishing

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara

Authors: Rimmelzwaan, Guus F; Sutter, Gerd

Source: Expert Review of Vaccines, Volume 8, Number 4, April 2009 , pp. 447-454(8)

Publisher: Expert Reviews

Preclinical and Clinical Development of a Multi-Envelope, DNA-Virus-Protein (D-V-P) HIV-1 Vaccine

Authors: Sealy, Robert; Slobod, Karen; Flynn, Patricia; Branum, Kristen; Surman, Sherri; Jones, Bart; Freiden, Pamela; Lockey, Timothy; Howlett, Nanna; Hurwitz, Julia

Source: International Reviews of Immunology, Volume 28, Numbers 1-2, February 2009 , pp. 49-68(20)

Publisher: Informa Healthcare

Smallpox vaccine: Encephalitis with acute disseminated encephalomyelitis: case report

Source: Reactions, Volume 1, Number 1239, 2009-02-14 , pp. 30-30(1)

Publisher: Adis International

Smallpox vaccine: Eczema vaccinatum in a child with atopic dermatitis: case report

Source: Reactions, Volume 1, Number 1236, 2009-01-24 , pp. 31-31(1)

Publisher: Adis International

High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4⁺ T cell responses more than 30 years post-vaccinia virus vaccination

Authors: Wang, M.; Tang, S. T.; Lund, O.; Dziegiel, M. H.; Buus, S.; Claesson, M. H.

Source: Clinical & Experimental Immunology, Volume 155, Number 3, March 2009 , pp. 441-446(6)

Publisher: Blackwell Publishing

IMVAMUNE^®: modified vaccinia Ankara strain as an attenuated smallpox vaccine

Authors: Kennedy, Jeffrey S; Greenberg, Richard N

Source: Expert Review of Vaccines, Volume 8, Number 1, January 2009 , pp. 13-24(12)

Publisher: Expert Reviews

Self-assembly of sapovirus recombinant virus-like particles from polyprotein in mammalian cells

Authors: Oka, Tomoichiro; Yamamoto, Mami; Miyashita, Kana; Ogawa, Satoko; Katayama, Kazuhiko; Wakita, Takaji; Takeda, Naokazu

Source: Microbiology and Immunology, Volume 53, Number 1, January 2009 , pp. 49-52(4)

Publisher: Blackwell Publishing

Therapeutic and prophylactic drugs to treat orthopoxvirus infections

Authors: Parker, Scott; Handley, Lauren; Buller, R Mark

Source: Future Virology, Volume 3, Number 6, November 2008 , pp. 595-612(18)

Publisher: Future Medicine

Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer

Authors: Tykodi, Scott S; Thompson, John A

Source: Expert Opinion on Biological Therapy, Volume 8, Number 12, December 2008 , pp. 1947-1953(7)

Publisher: Informa Healthcare